Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Jul 2014

Iglesia Michael D, Vincent Benjamin G, Parker Joel S, Hoadley Katherine A, Carey Lisa A, Perou Charles M, Serody Jonathan S

Abstract excerpt

PURPOSE: Lymphocytic infiltration of tumors predicts improved survival in patients with breast cancer. Previous studies have suggested that this survival benefit is confined predominantly to the basal-like subtype. Immune infiltration in ovarian tumors is also associated with improved prognosis....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B-Lymphocytes
Share to Breast Neoplasms
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Proportional Hazards Models

Share to Receptors, Antigen, B-Cell

Share to Sequence Analysis, RNA

Share to Transcriptome

Source

Open in PubMed Open full text

Identifiers

PMID: 24916698
DOI: 10.1158/1078-0432.CCR-13-3368
PMCID: PMC4102637

Genes

BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24916698-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.PMID 24916698Read ↗

Clonality, Antigen Recognition, and Suppression of CD8+ T Cells Differentially Affect Prognosis of Breast Cancer SubtypesSemantic proximity Read ↗

Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profilingSemantic proximity Read ↗

Immune gene expression profiling reveals heterogeneity in luminal breast tumorsSemantic proximity Read ↗

Development a prognostic risk model based on B cell-related immune genes in Ovarian Cancer by integrative analysis of single-cell and bulk RNA sequencing dataSemantic proximity Read ↗

Immune gene expression profiling reveals heterogeneity in luminal breast tumors.Semantic proximity Read ↗

Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profilingSemantic proximity Read ↗

Identification of tumor antigens and immune subtypes in breast cancer for mRNA vaccine developmentSemantic proximity Read ↗

Prognostically favorable immune responses to ovarian cancer are distinguished by self-reactive intra-epithelial plasma cellsSemantic proximity Read ↗

A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscapeSemantic proximity Read ↗

Identification of three subtypes of ovarian cancer and construction of prognostic models based on immune-related genes.Semantic proximity Read ↗

B-Cell–Mediated Immunity Predicts Survival of Patients With Estrogen Receptor–Positive Breast CancerSemantic proximity Read ↗

Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor BehaviorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.